|Seamac India Pharmaceuticals (P) Ltd.|
|302, Plot No. 22-23, Sundram Tower, Community Centre, Parchim Vihar, New Delhi-110063.|
Seamac India Pharmaceuticals (P) Ltd.
All Brands From Seamac India Pharmaceuticals (P) Ltd.
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor